Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$7.34 - $9.15 $780,836 - $973,386
106,381 Added 416.51%
131,922 $1.12 Million
Q4 2022

Feb 14, 2023

BUY
$7.79 - $8.98 $198,964 - $229,358
25,541 New
25,541 $221,000
Q4 2021

Feb 14, 2022

SELL
$2.83 - $7.26 $1.54 Million - $3.95 Million
-544,706 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$6.7 - $11.54 $444,665 - $765,886
-66,368 Reduced 10.86%
544,706 $4.21 Million
Q2 2021

Aug 16, 2021

BUY
$11.66 - $24.23 $7.13 Million - $14.8 Million
611,074 New
611,074 $7.13 Million

Others Institutions Holding VECT

# of Institutions
1
Shares Held
510K
Call Options Held
0
Put Options Held
0

About VectivBio Holding AG


  • Ticker VECT
  • Exchange NASDAQ
  • Description
  • VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for treatments of severe rare conditions. It develops apraglutide, a long-acting synthetic peptide analog of glucagon-like peptide-2 that is in Phase III clinical trial for the treatment of patients with sho...
More about VECT
Track This Portfolio

Track Pfm Health Sciences, LP Portfolio

Follow Pfm Health Sciences, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pfm Health Sciences, LP with notifications on news.